Lilly to Participate in Guggenheim Oncology Conference

INDIANAPOLIS , Feb. 1, 2022 /PRNewswire/ --  Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Oncology Conference on Wednesday, Feb. 9, 2022 . Jake Van Naarden, CEO of Loxo Oncology at Lilly and president, Lilly Oncology and David Hyman , M.D., chief medical officer, Lilly